GeneDx Holdings (WGS) Short-term Investments (2023 - 2026)

GeneDx Holdings (WGS) has reported Short-term Investments for 4 consecutive years, with $72.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Short-term Investments rose 19.51% year-over-year to $72.2 million in Q2 2026; TTM through Jun 2026 was $72.2 million, a 19.51% increase from a year earlier, with the FY2025 full-year figure at $66.3 million, up 18.42% from the prior year.
• Short-term Investments was $72.2 million for Q2 2026 at GeneDx Holdings, down from $76.8 million in the prior quarter.
• Over five years, Short-term Investments peaked at $76.8 million in Q1 2026 and troughed at $12.1 million in Q1 2023.
• A 4-year average of $50.6 million and a median of $58.6 million in 2024 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments jumped 140.77% in 2024 and climbed 0.93% in 2025, its largest moves.
• Over 4 years, Short-term Investments stood at $30.5 million in 2023, then soared by 83.72% to $56.0 million in 2024, then increased by 18.42% to $66.3 million in 2025, then grew by 8.97% to $72.2 million in 2026.
• The last three Short-term Investments figures came in at $72.2 million (Q2 2026), $76.8 million (Q1 2026), and $66.3 million (Q4 2025), per Business Quant data.